Schubert Jonckheer & Kolbe LLP advises Aquestive Therapeutics, Inc. (Nasdaq: AQST) investors that the firm is investigating potential legal claims arising from alleged false and misleading statements about the company’s drug candidate Anaphylm.
Read MoreNews and Investigations
We're actively investigating new cases on behalf of consumers, employees, and shareholders. If you've purchased any of these consumer products or own stock in any of these companies, please contact us to discuss your legal rights.
Schubert Jonckheer & Kolbe LLP is investigating potential wrongdoing at Humana Inc. (NYSE: HUM) following a court ruling that key claims in a securities fraud lawsuit against Humana and its former CEO and CFO will move forward.
Read MoreWe are advising Fastly, Inc. (NASDAQ: FSLY) investors that the firm is investigating potential legal claims arising from alleged false and misleading statements about growth and the impact of macroeconomic trends on the company’s business.
Read MoreWe are advising Lamb Weston Holdings, Inc. (NYSE: LW) investors that the firm is investigating potential legal claims arising from alleged false and misleading statements about the company’s efforts to modernize its business operations and systems.
Read MoreWe are advising Monolithic Power Systems, Inc. (NASDAQ: MPWR) investors that the firm is investigating potential legal claims arising from alleged false and misleading statements about the quality and performance of the company’s power management integrated circuits and its relationship with a key customer.
Read MoreWe are investigating a data breach that led to unauthorized access to the sensitive information of individuals affiliated with Radia Inc., P.S. (“Radia”), a Washington-based radiology group that serves over 50 clinics in Washington and Idaho.
Read More